Participating trials

The ATCG is a collaboration between different clinical trials carried out all over the world. The collaboration exists of the following clinical trials:

• ADD-ASPIRIN trial: Principal Investigator Ruth Langley
• ALASCCA trial: Principal Investigator Anna Martling
• ASCOLT trial: Principal Investigators John Chia and Eva Segelov
• ASAC trial: Principal Investigators Bjørn Atle Bjørnbeth, Kjetil Tasken and Sheraz Yaqub
• ASPIRIN trial: Principal Investigators Gerrit-Jan Liefers, Johanneke Portielje and Ricardo Fodde
• ASPIRIN trial Belgium: Principal Investigator Marc Peeters
• SAKK 41/13-Aspirin: Principal Investigator Ulrich Güller